The overlapping pathways between NF-κB, NLRP3, TREM2, and cGAS-STING indicate that pharmacological intervention in any one of these factors could lead to significant amelioration of neuroinflammation, thus cognitive improvement in AD patients. The gene discussed is NFKB1; the disease is Alzheimer disease.